Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Book value per share
MiniMed Group, Inc.'s book value per share at the end of fiscal 2026 was 14.1×, up 6.83% from 13.2× in fiscal 2025. At the end of the quarter to 31 July 2026 it was 12.9×. MiniMed Group, Inc. ranks 21st of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 14.1× | 6.83% |
| FY2025 | 13.2× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jul 2026 | 12.9× | — |
| Apr 2026 | 0.0× | — |
| Jan 2026 | 13.7× | — |
| Jul 2025 | 0.0× | — |
| 2 more quarters | Free account |
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICUI ICU Medical, Inc. compare | 87.6× |
| TFX Teleflex Incorporated compare | 66.7× |
| MMSI Merit Medical Systems, Inc. compare | 29.2× |
| NVST Envista Holdings Corporation compare | 19.2× |
| BLCO Bausch + Lomb Corporation compare | 18.2× |
| MMED MiniMed Group, Inc. | 12.9× |
| ATRC AtriCure, Inc. compare | 10.9× |
| STVN Stevanato Group S.p.A. compare | 6.7× |
| PLSE Pulse Biosciences, Inc compare | 2.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- The full statement